IRIS
CALABRESE, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.419
AS - Asia 2.060
EU - Europa 1.643
SA - Sud America 501
AF - Africa 50
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.336
RU - Federazione Russa 825
SG - Singapore 722
CN - Cina 593
BR - Brasile 412
IT - Italia 318
KR - Corea 218
VN - Vietnam 169
IE - Irlanda 164
HK - Hong Kong 152
IN - India 79
FI - Finlandia 66
DE - Germania 65
GB - Regno Unito 47
CA - Canada 35
MX - Messico 31
NL - Olanda 31
AR - Argentina 27
CI - Costa d'Avorio 23
AT - Austria 21
FR - Francia 20
EC - Ecuador 18
JP - Giappone 18
BD - Bangladesh 15
ES - Italia 14
PL - Polonia 14
ZA - Sudafrica 14
SE - Svezia 13
SA - Arabia Saudita 12
CO - Colombia 10
ID - Indonesia 10
PY - Paraguay 10
TR - Turchia 10
CZ - Repubblica Ceca 9
LT - Lituania 8
CL - Cile 7
IR - Iran 6
IQ - Iraq 5
UZ - Uzbekistan 5
VE - Venezuela 5
AZ - Azerbaigian 4
CH - Svizzera 4
JO - Giordania 4
KE - Kenya 4
PA - Panama 4
PE - Perù 4
PK - Pakistan 4
PS - Palestinian Territory 4
UY - Uruguay 4
JM - Giamaica 3
PT - Portogallo 3
TN - Tunisia 3
TW - Taiwan 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
MK - Macedonia 2
MY - Malesia 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CU - Cuba 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
Totale 12.671
Salva come PNG Salva come JPEG
Città #
Dallas 7.579
Singapore 442
Hefei 282
Moscow 247
Seoul 216
Santa Clara 175
Dublin 163
Hong Kong 151
Beijing 144
Ashburn 88
Siena 76
Milan 64
Ho Chi Minh City 57
Los Angeles 50
Bengaluru 44
Hanoi 41
São Paulo 31
Munich 29
Lappeenranta 27
Buffalo 24
Chicago 24
Helsinki 24
The Dalles 24
Abidjan 23
Florence 22
Redondo Beach 22
Nuremberg 21
New York 20
Rio de Janeiro 15
Turku 15
Mexico City 12
Rome 12
Guayaquil 11
Hyderabad 11
Warsaw 11
Columbus 10
Salt Lake City 10
Vienna 10
Brno 9
Brooklyn 9
Chennai 9
London 9
Stockholm 9
Amsterdam 8
Haiphong 8
Houston 8
Atlanta 7
Ceggia 7
Curitiba 7
Denver 7
Genoa 7
Johannesburg 7
Poplar 7
Querétaro 7
Tokyo 7
Bari 6
Belo Horizonte 6
Clifton 6
Goiânia 6
Guarulhos 6
Montreal 6
Recife 6
Salvador 6
Seravezza 6
Tehran 6
Thái Bình 6
Toronto 6
Asunción 5
Brasília 5
Düsseldorf 5
Ha Long 5
Hải Dương 5
Ottawa 5
Phoenix 5
Pisa 5
São Gonçalo 5
Tashkent 5
Baku 4
Council Bluffs 4
Frankfurt am Main 4
Gravataí 4
Indianapolis 4
Lille 4
Manchester 4
Miami 4
Mumbai 4
Porto Alegre 4
Portsmouth 4
Ribeirão Preto 4
Riyadh 4
Seattle 4
Shanghai 4
São Bernardo do Campo 4
Tampa 4
Amman 3
Ancona 3
Ankara 3
Arezzo 3
Biên Hòa 3
Bogotá 3
Totale 10.567
Salva come PNG Salva come JPEG
Nome #
009 The transcriptome of Sweet syndrome suggests a pathogenic role of both innate and adaptive immune signaling pathways 7.149
Advances in the Pathogenesis and Treatment of Rosacea: A Phenotype-Based Therapeutic Approach 152
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study 151
MAPK15 controls cellular responses to oxidative stress by regulating NRF2 activity and expression of its downstream target genes 148
Pso-Reg: a web registry for psoriasis in real life 137
Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris 129
Baricitinib: therapeutic potential for moderate to severe atopic dermatitis 127
Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a "real-world", mono-center experience 122
Diffuse purpuric pityriasis versicolor: a peculiar presentation 121
Characteristics of primary cutaneous lymphoma in Italy: a tertiary care, single-center study 120
Characterisation of IL-1 family members in Sweet syndrome highlights the overexpression of IL-1β and IL-1R3 as possible therapeutic targets 120
Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin 120
Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose? 120
Erfolgreiche Behandlung des therapierefraktären Sweet-Syndroms mit Adalimumab 116
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice 113
Clinical response to brodalumab in a patient affected by refractory SAPHO syndrome 112
Line-field confocal optical coherence tomography for the diagnosis of skin carcinomas: real-life data over three years 110
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous Lymphomas 109
Belimumab as a potential therapeutic option for bullous systemic lupus erythematosus 103
Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases* 103
Eyelid contact dermatitis: 25-year single-center retrospective study 103
Erythema annulare centrifugum as clinical manifestation of-eosinophilic granulomatosis with polyangiitis 100
Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma 99
Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease 98
Short-, mid- and long-term efficacy of dupilumab in moderate to severe atopic dermatitis: a real life multicenter Italian study on 2576 patients 95
Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg? 93
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study 92
Molecular Characteristics of Sweet Syndrome: A Systematic Review 92
Line-field confocal optical coherence tomography in alopecia areata and histopathological correlation 91
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 91
Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition 91
The corkscrew hairs of tinea capitis through line-field confocal optical coherence tomography 90
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still's Disease Registry 88
Efficacy and safety of biologics for hidradenitis suppurativa: A network meta-analysis of phase III trials 87
Investigational systemic drugs for moderate to severe plaque psoriasis: What’s new? 87
Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients 86
Psoriasis and fibromyalgia: a systematic review 86
Italian Consensus on the treatment of oral lichen planus 84
Overview of Atopic Dermatitis in Different Ethnic Groups 83
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa 82
Risk of Skin Cancer in Patients with Psoriasis: Single-Center Retrospective Study Comparing Anti-TNFα and Phototherapy 82
The role of NLRP1 inflammasome in skin cancer and inflammatory skin diseases 82
Psoriasis and its management in women of childbearing age: tools to increase awareness in dermatologists and patients 82
725 Characterizing the transcriptional landscape of pyoderma gangrenosum and its main differential diagnoses 81
Fibromyalgia and Skin Disorders: A Systematic Review 80
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa 80
Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis 79
Hyper-IgD syndrome and hidradenitis suppurativa: an intriguing link 78
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis 77
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies 77
From Bank Preparation to Clinical Use of Homologous Skin Allografts in Wound Healing: A Sustainable Approach 77
Successful treatment of pyoderma gangrenosum with composite grafting of acellular dermal matrix and glycerolized skin: a preliminary experience 76
Tildrakizumab in moderate-to-severe plaque psoriasis: a multicenter, retrospective, real-life study 74
Severe and resistant palmar psoriasis successfully treated with risankizumab 72
Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses 71
Novel therapeutic strategies in the topical treatment of atopic dermatitis 66
Recalcitrant Sweet Syndrome successfully treated with adalimumab 65
Sweet syndrome: an update on clinical aspects, pathophysiology, and treatment 64
117 Indiscernible skin transcriptome in Stevens-Johnson syndrome and toxic epidermal necrolysis induced by immune checkpoint inhibitors and other culprit drugs 61
Use of JAK Inhibitors in Lichen Planus: An Update 58
Upadacitinib for Treatment-Resistant Urticarial Vasculitis: A Case Study and Therapeutic Insight 55
Design and development of a systematic validation protocol for synthetic melanoma images for responsible use in medical artificial intelligence 46
Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study 42
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 25
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry 24
Totale 12.974
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.299
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20232 0 0 0 0 0 0 0 0 0 0 0 2
2023/2024511 2 1 1 125 41 61 113 15 26 29 50 47
2024/20252.005 39 80 188 104 190 72 64 141 148 144 169 666
2025/202610.456 427 2.481 5.824 891 805 28 0 0 0 0 0 0
Totale 12.974